Related Experiment Video
Updated: Jan 25, 2026

Genetic Variant Detection in the CALR gene using High Resolution Melting Analysis
Published on: August 26, 2020
Congenital diarrhea/enteropathy due to a novel biallelic PERCC1 variant - a case-based review and variant analysis
Aaqib Zaffar Banday1, Ishaq Malik2, Anit Kaur3
1Department of Pediatrics, Government Medical College Srinagar, Kashmir, India. maaqibzb@gmail.com.
Abstract:
Congenital diarrhea/enteropathy due to inherited biallelic defects in the newly discovered gene PERCC1 has been reported in only a few patients thus far. We utilized whole-exome sequencing (WES) to identify a novel PERCC1 stop-gain variant (c.188C>G, p.Ser63*). Literature review identified 16 additional patients - 13 with large biallelic deletions involving the PERCC1 gene and three with a homozygous single-nucleotide (stop-gain) variant (c.390C>G, p.Tyr130*). Median [range] age at onset of diarrhea in patients with available data (including ours) is 9.5 [1-21] days. Chronic intractable diarrhea often results in growth failure, meriting the utilization of parenteral nutrition (PN), especially during the first few years of life. Discontinuation of PN has been reported in six patients at an age of 8 [4-17] years. Our report highlights the role of WES in identifying PERCC1 variants in patients with congenital diarrhea/enteropathy. Thus far, PERCC1 variants have primarily been identified through targeted testing or whole-genome sequencing.
Related Concept Videos
Histone Variants at the Centromere
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Classification of Titrimetric Analysis Based on Reaction Types
Titrations between an acid and a base lead to neutralization reactions that form...
Qualitative Analysis
For instance, group IV...

